Baxter to Host Annual Meeting of Stockholders in Virtual Format
28 March 2024 - 12:00AM
Business Wire
Baxter International Inc. (NYSE:BAX), a global medtech leader,
will host its Annual Meeting of Stockholders (the 2024 Annual
Meeting) in a virtual format on Tuesday, May 7, 2024 at 9 a.m.,
Central Time, as disclosed in Baxter’s proxy statement for the 2024
Annual Meeting. Online access to the 2024 Annual Meeting will begin
at 8:45 a.m., Central Time. Stockholders will not be able to attend
the 2024 Annual Meeting in person. The virtual format provides a
convenient and cost-effective experience to all stockholders and
employees regardless of location.
As always, whether or not a stockholder plans to attend the
virtual 2024 Annual Meeting, all stockholders of record are
encouraged to vote their shares prior to the 2024 Annual Meeting by
one of the methods described in the proxy materials for the 2024
Annual Meeting.
Attending the 2024 Annual Meeting
Stockholders of record may attend the 2024 Annual Meeting by
accessing www.virtualshareholdermeeting.com/BAX2024 and entering
their 16-digit control number on their proxy card or notice of
availability of proxy materials. Stockholders that hold shares in
“street name” (i.e., through an account at a broker or other
nominee), should follow their broker’s or nominee’s instructions to
obtain their 16-digit control number or otherwise attend through
the broker or nominee. A list of Baxter's stockholders of record
will be available for examination by stockholders on the 2024
Annual Meeting website during the meeting.
Asking Questions
Stockholders of record may submit questions in two ways.
Stockholders may ask a question before the 2024 Annual Meeting,
beginning at 9 a.m., Central Time, on April 30, 2024 and until
11:59 p.m., Central Time, on May 6, 2024, by logging into
www.proxyvote.com and entering their 16-digit control number. Once
past the login screen, stockholders should click on “Question for
Management,” type in a question and click “Submit.” Alternatively,
stockholders of record will be able to submit questions live during
the 2024 Annual Meeting by accessing the meeting at
www.virtualshareholdermeeting.com/BAX2024, typing a question into
the “Ask a Question” field and clicking “Submit.” Only questions
pertinent to 2024 Annual Meeting matters will be answered during
the meeting, subject to time constraints. If any questions
pertinent to 2024 Annual Meeting matters cannot be answered during
the meeting due to time constraints, Baxter will post and answer a
representative set of these questions online at
https://investor.baxter.com. The questions and answers will be
available as soon as reasonably practicable after the 2024 Annual
Meeting and will remain available until one week after posting.
Voting Shares at the 2024 Annual Meeting
Stockholders that have not voted their shares prior to the 2024
Annual Meeting will be able to vote their shares electronically at
the 2024 Annual Meeting by clicking “Vote Here” on the meeting
website.
Stockholders may continue to vote their shares prior to the 2024
Annual Meeting. If a stockholder has already voted their shares
using one of the methods described in the proxy materials for the
2024 Annual Meeting, they do not need to vote again.
Attending the 2024 Annual Meeting as a Guest
Anyone who would like to attend the 2024 Annual Meeting as a
guest in listen-only mode can do so by accessing the Meeting at
www.virtualshareholdermeeting.com/BAX2024 and by entering the
information requested on the screen. Please note guests will not
have the ability to ask questions or vote during the 2024 Annual
Meeting.
About Baxter
Every day, millions of patients, caregivers and healthcare
providers rely on Baxter’s leading portfolio of diagnostic,
critical care, kidney care, nutrition, hospital and surgical
products used across patient homes, hospitals, physician offices
and other sites of care. For more than 90 years, we’ve been
operating at the critical intersection where innovations that save
and sustain lives meet the healthcare providers who make it happen.
With products, digital health solutions and therapies available in
more than 100 countries, Baxter’s employees worldwide are now
building upon the company’s rich heritage of medical breakthroughs
to advance the next generation of transformative healthcare
innovations. To learn more, visit www.baxter.com and follow us on
X/Twitter, LinkedIn and Facebook.
Baxter is a registered trademark of Baxter International
Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240327221279/en/
Media Contact Steve Brett, (224) 948-5353
media@baxter.com Investor Contact Clare Trachtman, (224)
948-3020
Baxter (NYSE:BAX)
Historical Stock Chart
From May 2024 to Jun 2024
Baxter (NYSE:BAX)
Historical Stock Chart
From Jun 2023 to Jun 2024